These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23974620)

  • 1. Records and record-keeping for the hospital compounding pharmacist.
    McElhiney LF
    Int J Pharm Compd; 2007; 11(2):136-41. PubMed ID: 23974620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of United States pharmacopeia chapter 795 and american society of health-system pharmacists guidelines for nonsterile compounding.
    McElhiney LF
    Int J Pharm Compd; 2009; 13(6):525-30. PubMed ID: 23965326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipment, supplies, and facilites required for hospital compounding.
    McElhiney LF
    Int J Pharm Compd; 2006; 10(6):436-41. PubMed ID: 23974417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to hospital compounding.
    McElhiney LF
    Int J Pharm Compd; 2006; 10(4):245-50. PubMed ID: 23974255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance.
    Greeson NM; Mixon W; Allan WC
    Int J Pharm Compd; 2020; 24(5):371-379. PubMed ID: 32886634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Education, training, and evaluation of hospital compounding personnel.
    McElhiney LF
    Int J Pharm Compd; 2006; 10(5):361-8. PubMed ID: 23974315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond-use dating, labeling, delivery, and storage of compounded and repackaged medications in a hospital or institutional setting.
    McElhiney LF
    Int J Pharm Compd; 2008; 12(4):316-20. PubMed ID: 23969767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United States pharmacopeia convention standards and clinical information for compounded medications used in veterinary medicine.
    Deveau I
    Int J Pharm Compd; 2007; 11(5):357-62. PubMed ID: 23969515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased regulation of medication compounding by state boards of pharmacy.
    Reynolds KA; Ibrahim SA; Hellquist KA; Poon E; Alam M
    Arch Dermatol Res; 2022 Oct; 314(8):787-790. PubMed ID: 34698896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of USP Chapter 797 Compliance By A 35-Bed Rural Hospital: A Case Study.
    Peters GF; McKeon MR; Nerburn RG
    Int J Pharm Compd; 2007; 11(6):450-70. PubMed ID: 23994807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2008; 12(1):74-82. PubMed ID: 23969574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2010; 14(2):142-9. PubMed ID: 23965426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounded medications in a hospital setting: patient counseling and staff education.
    McElhiney LF
    Int J Pharm Compd; 2009; 13(3):224-9. PubMed ID: 23966477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the proposed revision process for United States phamacopeia chapter 797 pharmacuetical compounding-sterile preparations.
    Okeke CC
    Int J Pharm Compd; 2007; 11(4):302-5. PubMed ID: 23974789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obtaining accreditation by the pharmacy compounding accreditation board, part 1: an overview.
    Cabaleiro J
    Int J Pharm Compd; 2007; 11(4):297-8. PubMed ID: 23974788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing a quality-assurance program for hospital compounding.
    McElhiney LF
    Int J Pharm Compd; 2008; 12(2):116-20. PubMed ID: 23969604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.